Pharmacokinetics and pharmacodynamics of an orally disintegrating tablet formulation of dexlansoprazole

Background: The pharmacokinetics and pharmacodynamics of a novel orally disintegrating tablet (ODT) formulation of delayed-release dexlansoprazole 30 mg was evaluated versus the dexlansoprazole 30 mg capsule in this phase I, open-label, multiple-dose, randomized, two-period crossover study. Methods:...

Full description

Bibliographic Details
Main Authors: Michael Kukulka, Sai Nudurupati, Maria Claudia Perez
Format: Article
Language:English
Published: SAGE Publishing 2016-11-01
Series:Therapeutic Advances in Gastroenterology
Online Access:https://doi.org/10.1177/1756283X16670073

Similar Items